Christina M. Cusack

Christina M. Cusack serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirements development through contract award and administration. She plays a critical role in ensuring compliance with federal procurement regulations while aligning contracting actions with agency mission objectives. Her portfolio primarily encompasses professional and technical services, with a strong emphasis on consulting, scientific research, and specialized laboratory equipment. Cusack routinely handles competitive procurements under FAR Part 15, utilizing negotiated contracting methods to secure high-value, complex solutions that support technical and operational needs across mission-critical domains. While specific contractor names are not available, Cusack maintains a balanced approach to vendor engagement, fostering relationships with both large-capability firms and small businesses capable of delivering specialized technical services. Her contracting patterns reflect a preference for open competition, with the majority of awards issued under unrestricted solicitations. She actively collaborates with industry partners who demonstrate technical proficiency in analytical instrumentation, management consulting, and scientific support services, ensuring that procurement outcomes meet rigorous performance and compliance standards. Cusack demonstrates a clear commitment to socioeconomic contracting, with 21.4% of her awards designated for 8(a) competed set-asides. This reflects a deliberate effort to promote opportunities for small disadvantaged businesses while maintaining competitive integrity. Her procurement strategy balances small business participation with the need for qualified vendors capable of delivering complex technical solutions, aligning with federal goals to expand equitable access to government contracting. Her primary NAICS focus areas include Other Scientific and Technical Consulting Services (541690) and Administrative Management Consulting (541611), alongside significant activity in Analytical Laboratory Instrument Manufacturing (334516) and In-Vitro Diagnostic Substance Manufacturing (325413). This specialization underscores her expertise in procuring advanced scientific tools, diagnostic technologies, and strategic advisory services critical to research, public health, and technical operations.